π¬ Moderna starts Ebola trial in Africa
Moderna has initiated a Phase I clinical trial for its Ebola vaccine. The study is taking place in various locations across Africa. The trial commenced on October 1st, involving initial cohorts of participants. This research is part of broader efforts to prepare the continent for future health challenges. Further data collection and analysis will determine the next steps for the vaccine's development. π¬